Wealthfront Inc. acquired a new stake in shares of Agilent Technologies Inc (NYSE:A) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 10,046 shares of the medical research company’s stock, valued at approximately $673,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. grew its position in shares of Agilent Technologies by 8.1% during the fourth quarter. BlackRock Inc. now owns 25,665,358 shares of the medical research company’s stock worth $1,718,808,000 after buying an additional 1,912,186 shares in the last quarter. TimesSquare Capital Management LLC acquired a new stake in shares of Agilent Technologies during the third quarter worth approximately $58,550,000. Bank of Montreal Can grew its position in shares of Agilent Technologies by 187.3% during the fourth quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock worth $49,693,000 after buying an additional 483,721 shares in the last quarter. Wells Fargo & Company MN grew its position in shares of Agilent Technologies by 27.6% during the third quarter. Wells Fargo & Company MN now owns 2,184,502 shares of the medical research company’s stock worth $140,244,000 after buying an additional 473,047 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Agilent Technologies by 47.1% during the third quarter. Principal Financial Group Inc. now owns 1,315,644 shares of the medical research company’s stock worth $84,465,000 after buying an additional 421,438 shares in the last quarter.
In other news, VP Mark Doak sold 4,154 shares of the business’s stock in a transaction on Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total transaction of $278,318.00. Following the completion of the transaction, the vice president now owns 68,270 shares of the company’s stock, valued at $4,574,090. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the transaction, the chief executive officer now directly owns 324,687 shares of the company’s stock, valued at approximately $24,351,525. The disclosure for this sale can be found here. In the last ninety days, insiders sold 154,707 shares of company stock valued at $10,944,828.
Agilent Technologies Inc (NYSE A) opened at $71.25 on Thursday. The company has a market cap of $22,938.75, a price-to-earnings ratio of 28.43, a price-to-earnings-growth ratio of 2.38 and a beta of 1.28. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40. Agilent Technologies Inc has a 1-year low of $50.86 and a 1-year high of $75.00.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 14th. The medical research company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.08. The firm had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.16 billion. Agilent Technologies had a net margin of 4.25% and a return on equity of 17.70%. During the same quarter in the previous year, the company posted $0.53 earnings per share. equities analysts forecast that Agilent Technologies Inc will post 2.67 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.tickerreport.com/banking-finance/3214785/wealthfront-inc-acquires-shares-of-10046-agilent-technologies-inc-a.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.